BRUSSELS (Reuters) - AstraZeneca is not doing enough to try to resolve a dispute over delayed COVID-19 vaccine deliveries to the European Union, the bloc's top health official said on Monday, as news emerged the drugmaker is also facing supply problems elsewhere.
In a sign of the EU's frustration - after Pfizer also announced a temporary slowdown in vaccine supplies earlier in January - EU health commissioner Stella Kyriakides proposed forcing drugmakers to register in advance their COVID-19 vaccine exports, so the bloc can keep track of what they are doing.